PExA
0.27 SEK
Less than 1K followers
PEXA B
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.26 %
+40.93 %
+14.29 %
+49.65 %
+69.75 %
+21.42 %
-44.72 %
-80.85 %
-86.99 %
PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.
Read moreMarket cap
33.76M SEK
Turnover
-
Revenue
720K
EBIT %
-1,445.83 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19/2
2026
Annual report '25
All
Press releases
ShowingAll content types
PExA: 27 miljoner från Cancerfonden till Sandra Lindstedts grupp i Lund för tidig upptäckt av lungcancer
PExA: VD-presentation i samband med Q3 publicerad
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools